The divide between compensation for R&D staff in industry and academia continues to widen. Median average salary in a private organization is now $30,000 more than in academia. Despite the economic downturn, life sciences execs as a whole are targeting a 9% average increase in their cash compensation in 2008; CEOs are even more aggressive, aiming for an average 12% rise to ∼$400,000. Top execs based in New England make the most on average; those in the Midwest receive 20–33% less.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lawrence, S. Compensation continues rise. Nat Biotechnol 27, 14 (2009). https://doi.org/10.1038/nbt0109-14
Issue Date:
DOI: https://doi.org/10.1038/nbt0109-14
